$TCMD

Tactile Systems Technology (NASDAQ:TCMD) VP Sells $148,260.15 in Stock

Tactile Systems Technology (NASDAQ:TCMD) VP Kristie Burns sold 5,139 shares of company stock for $148,260.15 on January 2nd, reducing her stake by 6.63%. This transaction follows an earnings beat for the company, which reported EPS of $0.36 against an expected $0.16 and revenue of $85.76 million versus $79.31 million projected. Shares traded up 1.2% to $30.50, and institutional investors own 83.43% of the stock.

Original reporting
MarketBeat · MarketBeat
Published Jan 7, 2026, 10:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jan 7, 2026, 10:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tactile Systems Technology (NASDAQ:TCMD) VP Sells $148,260.15 in Stock — source image
Decision brief

The 30-second read

$TCMDNeutralMed
01

Why it matters

The insider sale occurred shortly after positive earnings, suggesting profit-taking rather than fundamental concerns.

02

Market read

The news is relevant for traders focusing on healthcare stocks, especially those with insider activity and earnings surprises.

03

What to watch

The insider sale might be for personal liquidity needs; the company's fundamentals remain strong.

Relevance 6/10Timing: Immediate, as the insider sale occurred on January 2nd and news was published on January 6th.

Background

Tactile Systems Technology reported a strong earnings beat, with EPS of $0.36 against an expected $0.16, and revenue surpassing estimates.

Company-level read

Ticker impact

$TCMDNeutralMedium confidence
Context

High relevance due to insider stock sale following strong earnings report.

Expected impact

Minimal short-term price movement expected; potential slight downward pressure due to insider selling, but offset by positive earnings.

Evidence & confidence

Insider sales can be for personal reasons and do not always indicate a negative outlook. The company's strong earnings and revenue beat suggest underlying strength.

Market effects

Potential positive sentiment in the healthcare equipment sector, as Tactile Systems operates within this space.

Limited, as the news pertains to a U.S.-listed company with high institutional ownership.

Negligible, unless the company is a market leader or significantly influences global healthcare markets.

Counterpoint

Insider selling could indicate upcoming challenges not yet reflected in earnings, warranting caution.

Key entities

  • Kristie Burns

    Senior executive involved in the stock sale.

  • Tactile Systems Technology

    Provider of medical devices and services in the healthcare sector.

Related articles

$TCMDMedAI 8/10

Tactile Systems Technology (TCMD) Q2 2026 Earnings Call Transcript

Tactile Systems Technology (TCMD) reported Q2 2026 revenue of $85.7M, up 9% Y/Y, driven by lymphedema revenue of $73.6M (+12%). Airway clearance revenue fell 7% to $12.1M due to distributor inventory dynamics. Gross margin was 76.3%. Adjusted EBITDA rose to $11.4M (+49%). FY2026 revenue guidance was set at $360M-$366M and EBITDA at $49M-$51M.

$TCMDMed

Tactile Systems Technology, Inc. Q2 2026 Earnings Call Summary

Tactile Systems Technology reported Q2 2026 results: lymphedema revenue rose 12% YoY on Flexitouch adoption, while airway clearance revenue fell 7% as large DME partners paused orders amid elevated inventory. Gross margin increased 180 bps to 76.3%. Full-year 2026 revenue guidance was raised to $360m-$366m; MyoSleeve launch and LymphaTech FDA submission are ongoing.

$TCMDHigh

Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results

TACTILE SYSTEMS TECHNOLOGY INC (TCMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results MINNEAPOLIS, MN, August 10th, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ch

$TCMDMedAI 8/10

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

Tactile Medical (Nasdaq: TCMD) announced the full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation system. The company says it keeps the same use for chronic neuromuscular and respiratory conditions such as cystic fibrosis and bronchiectasis across ages, while adding a lighter, more adjustable vest and a redesigned controller. It also includes built-in Wi‑Fi/Bluetooth for connected care and clinician/payer data.

$JPMLow

JPMorgan Chase is Delving Further Into National Security With $5 Billion Push

JPMorgan Chase has invested over $5 billion in U.S. national security and industrial capacity, exceeding initial plans. The bank may expand its $10 billion commitment, with investments in defense, manufacturing, and frontier technologies. Recipients include Hadrian and Castelion, focusing on automated factories and hypersonic missiles. The initiative aims to reduce foreign dependence and support long-term growth.

$OSKMed

Moody’s upgrades Oshkosh to Baa2 on strengthening business mix and stable outlook

Moody's upgraded Oshkosh Corporation's (NYSE:OSK) rating to Baa2 from Baa3, citing a stronger business mix and stable outlook. The company's focus on Vocational and Transport segments is expected to drive revenue growth of 3% in 2026 and 9% in 2027, with EBITA margins expanding to around 9% by 2027. Moody's projects solid free cash flow and financial leverage below 1.5x through 2027.